{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:33:50Z","timestamp":1774438430264,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10072-017-2833-9","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:58:01Z","timestamp":1485997081000},"page":"727-743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann\u2013Pick type C disease: review of initial published cases"],"prefix":"10.1007","volume":"38","author":[{"given":"Juan Eduardo","family":"Meg\u00edas-Vericat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Garc\u00eda-Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Company-Albir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Fern\u00e1ndez-Meg\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Carlos","family":"P\u00e9rez-Miralles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"L\u00f3pez-Briz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonaventura","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Poveda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"2833_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier MT (2010) Niemann-Pick disease type C. Orphanet J Rare Dis 5:16. doi:\n                        10.1186\/1750-1172-5-16","journal-title":"Orphanet J Rare Dis"},{"key":"2833_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1750-1172-8-166","volume":"8","author":"E Mengel","year":"2013","unstructured":"Mengel E, Kl\u00fcnemann H-H, Louren\u00e7o CM, Hendriksz CJ, Sedel F, Walterfang M et al (2013) Niemann-Pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis 8:166. doi:\n                        10.1186\/1750-1172-8-166","journal-title":"Orphanet J Rare Dis"},{"key":"2833_CR3","unstructured":"Patterson M (2013) Niemann-Pick Disease Type C. GeneReviews\u00ae. University of Washington. \n                        http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1296\/\n                        \n                    . Accessed 06 May 2016"},{"key":"2833_CR4","doi-asserted-by":"publisher","first-page":"e816593","DOI":"10.1155\/2015\/816593","volume":"2015","author":"H Alobaidy","year":"2015","unstructured":"Alobaidy H (2015) Recent advances in the diagnosis and treatment of Niemann-Pick disease type c in children: a guide to early diagnosis for the general pediatrician. Int J Pediatr 2015:e816593. doi:\n                        10.1155\/2015\/816593","journal-title":"Int J Pediatr"},{"issue":"3","key":"2833_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","volume":"106","author":"Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F, NP-C Guidelines Working Group","year":"2012","unstructured":"Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F, NP-C Guidelines Working Group (2012) Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab 106(3):330\u2013344. doi:\n                        10.1016\/j.ymgme.2012.03.012","journal-title":"Mol Genet Metab"},{"key":"2833_CR6","unstructured":"Orphanet: An online database of rare diseases and orphan drugs. Copyright, 1997. Available INSERM \n                        http:\/\/www.orpha.net\n                        \n                    . Accessed 06 May 2016"},{"key":"2833_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1172-8-12","volume":"8","author":"MC Patterson","year":"2013","unstructured":"Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H et al (2013) Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis 8:12. doi:\n                        10.1186\/1750-1172-8-12","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2833_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/jnnp.74.4.528","volume":"74","author":"KA Josephs","year":"2003","unstructured":"Josephs KA, Gerpen MWV, Gerpen JAV (2003) Adult onset Niemann-Pick disease type C presenting with psychosis. J Neurol Neurosurg Psychiatry 74(4):528\u2013529. doi:\n                        10.1136\/jnnp.74.4.528","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2833_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40265-013-0164-6","volume":"74","author":"KA Lyseng-Williamson","year":"2014","unstructured":"Lyseng-Williamson KA (2014) Miglustat: a review of its use in Niemann-Pick disease type C. Drugs 74(1):61\u201374. doi:\n                        10.1007\/s40265-013-0164-6","journal-title":"Drugs"},{"issue":"3","key":"2833_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/1568026613666131127160118","volume":"14","author":"EA Ottinger","year":"2014","unstructured":"Ottinger EA, Kao ML, Carrillo-Carrasco N, Yanjanin N, Shankar RK, Janssen M et al (2014) Collaborative development of 2-hydroxypropyl-\u03b2-cyclodextrin for the treatment of Niemann-Pick type C1 disease. Curr Top Med Chem 14(3):330\u2013339. doi:\n                        10.2174\/1568026613666131127160118","journal-title":"Curr Top Med Chem"},{"issue":"7","key":"2833_CR11","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1073\/pnas.0810895106","volume":"106","author":"B Liu","year":"2009","unstructured":"Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, Dietschy J (2009) Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2212\/\u2212 mouse. Proc Natl Acad Sci USA 106(7):2377\u20132382. doi:\n                        10.1073\/pnas.0810895106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2833_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1194\/jlr.M000257","volume":"51","author":"B Liu","year":"2010","unstructured":"Liu B, Ramirez CM, Miller AM, Repa JJ, Turley SD, Dietschy JM (2010) Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid. J Lipid Res 51(5):933\u2013944. doi:\n                        10.1194\/jlr.M000257","journal-title":"J Lipid Res"},{"issue":"4","key":"2833_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1203\/00006450-201011001-00604","volume":"68","author":"CM Ramirez","year":"2010","unstructured":"Ramirez CM, Liu B, Taylor AM, Repa JJ, Burns DK, Weinberg AG et al (2010) Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life. Pediatr Res 68(4):309\u2013315. doi:\n                        10.1203\/00006450-201011001-00604","journal-title":"Pediatr Res"},{"issue":"1","key":"2833_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1203\/00006450-201011001-00099","volume":"68","author":"S Ward","year":"2010","unstructured":"Ward S, O\u2019Donnell P, Fernandez S, Vite CH (2010) 2-hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease. Pediatr Res 68(1):52\u201356. doi:\n                        10.1203\/00006450-201011001-00099","journal-title":"Pediatr Res"},{"issue":"9","key":"2833_CR15","doi-asserted-by":"publisher","first-page":"e6951","DOI":"10.1371\/journal.pone.0006951","volume":"4","author":"CD Davidson","year":"2009","unstructured":"Davidson CD, Ali NF, Micsenyi MC, Stephney G, Renault S, Dobrenis K et al (2009) Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One 4(9):e6951. doi:\n                        10.1371\/journal.pone.0006951","journal-title":"PLoS One"},{"key":"2833_CR16","doi-asserted-by":"publisher","unstructured":"Vite CH, Bagel JH, Swain GP, Prociuk M, Sikora TU, Stein VM et al (2015) Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease. Sci Transl Med 7(276):276ra26. doi:\n                        10.1126\/scitranslmed.3010101","DOI":"10.1126\/scitranslmed.3010101"},{"issue":"25","key":"2833_CR17","doi-asserted-by":"publisher","first-page":"9404","DOI":"10.1523\/JNEUROSCI.1317-11.2011","volume":"31","author":"A Aqul","year":"2011","unstructured":"Aqul A, Liu B, Ramirez CM, Pieper AA, Estill SJ, Burns DK, Repa JJ, Turley SD, Dietschy JM (2011) Unesterified cholesterol accumulation in late endosomes\/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment. J Neurosci 31(25):9404\u20139413. doi:\n                        10.1523\/JNEUROSCI.1317-11.2011","journal-title":"J Neurosci"},{"key":"2833_CR18","unstructured":"FDA letter from Dr. Timothy Cote and OOPD (2010) Designation Request# 10-3039"},{"key":"2833_CR19","unstructured":"European Medicines Agency(2015) Public summary of opinion on orphan designation EMA\/COMP\/546608\/2011.2010. \n                        http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Orphan_designation\/2011\/09\/WC500112733.pdf\n                        \n                    . Accessed 06 May 2016"},{"issue":"3","key":"2833_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10545-012-9583-x","volume":"36","author":"CC Pontikis","year":"2013","unstructured":"Pontikis CC, Davidson CD, Walkley SU, Platt FM, Begley DJ (2013) Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood\u2013brain barrier permeability. J Inherit Metab Dis 36(3):491\u2013498. doi:\n                        10.1007\/s10545-012-9583-x","journal-title":"J Inherit Metab Dis"},{"key":"2833_CR21","unstructured":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (2014) NCT01747135. Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease. ClinicalTrials.gov. National Institutes of Health Clinical Center. \n                        https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01747135\n                        \n                    . Accessed 06 May 2016"},{"key":"2833_CR22","unstructured":"Vtesse Inc. (2015) NCT02534844. Study of 2-hydroxypropyl-\u03b2-cyclodextrin (VTS-270) to Treat Niemann-Pick Type C1 (NPC1) Disease. ClinicalTrials.gov. National Institutes of Health Clinical Center. \n                        https:\/\/clinicaltrials.gov\/ct2\/show\/\n                        \n                     NCT02534844. Accessed 06 May 2016"},{"key":"2833_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"Moher D, Liberati A, Tetzlaff J, Altman DG, and the PRISMA Group","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, and the PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264\u2013269. doi:\n                        10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Ann Intern Med"},{"issue":"2","key":"2833_CR24","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.ymgme.2011.11.072","volume":"105","author":"C Hastings","year":"2012","unstructured":"Hastings C, Torkildson J, Raphael R (2012) Intrathecal hydroxy-propyl-beta-cyclodextrin reverses hearing loss in identical twin girls with Niemann-Pick type C disease. Mol Genet Metab 105(2):S34. doi:\n                        10.1016\/j.ymgme.2011.11.072","journal-title":"Mol Genet Metab"},{"key":"2833_CR25","unstructured":"Hastings C (2010) Request for intrathecal delivery of HPBCD for Niemann Pick Type C patients, Caroline Hastings, M.D. Principal Investigator Department of Pediatric Hematology Oncology Children\u2019s Hospital and Research Center Oakland Submission Date to FDA: August 13, 2010. \n                        http:\/\/addiandcassi.com\/wordpress\/wp-content\/uploads\/Hempel-Cyclodextrin-Intrathecal-FDA-Filing-2010-Aug.pdf\n                        \n                    . Accessed 06 May 2016"},{"key":"2833_CR26","unstructured":"Berry-Kravis E, O\u2019Keefe J, Pounardjian, Chin J, Porter FD, Ory D, et al. (2014) Intermediate size patient population IND for 2-hydroxypropyl-cyclodextrin (HP-CD) outpatient treatment of siblings with Niemann-Pick type C1 (NP-C1) and disparate rates of progression: exploration of outcome measures and biomarkers. Michael, Marcia, and Christa Parseghian Scientific Conference for Niemann-Pick Type C Research June 12-14, 2014. Abstract 6:17. \n                        https:\/\/niemannpick.nd.edu\/assets\/135126\/2014abstractbooklet.pdf\n                        \n                    . Accessed 06 May 2016"},{"issue":"s18","key":"2833_CR27","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1002\/ana.24226","volume":"76","author":"E Berry-Kravis","year":"2014","unstructured":"Berry-Kravis E, O\u2019Keefe J, Pounardjian T, Chin J, Porter FD, Ory D et al (2014) Intermediate size patient population IND for 2-hydroxypropyl-\u00df-cyclodextrin (HP-\u00df-CD) outpatient treatment of siblings with Neimann\u2013Pick type C1 (NP-C1) and disparate rates of progression: exploration of outcome measures and biomarkers. Ann Neurol 76(s18):S215\u2013S216. doi:\n                        10.1002\/ana.24226","journal-title":"Ann Neurol"},{"key":"2833_CR28","unstructured":"Berry-Kravis E, O\u2019Keefe J, Hoffmann A, Winston A, LaGorio L, Robertson E et al (2015) Objective clinical efficacy outcome measures for cyclodextrin treatment in Niemann-Pick type C (NP-C): a five-domain approach. michael, marcia, and christa parseghian scientific conference for Niemann-Pick type C research June 11\u201313, 2015. Abstract 13:23. \n                        https:\/\/niemannpick.nd.edu\/assets\/168424\/2015abstractbooklet.pdf\n                        \n                    . Accessed 06 May 2016"},{"issue":"1\u20132","key":"2833_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ymgme.2015.07.001","volume":"116","author":"TJ Maarup","year":"2015","unstructured":"Maarup TJ, Chen AH, Porter FD, Farhat NY, Ory DS, Sidhu R et al (2015) Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1. Mol Genet Metab 116(1\u20132):75\u201379. doi:\n                        10.1016\/j.ymgme.2015.07.001","journal-title":"Mol Genet Metab"},{"issue":"3","key":"2833_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.7399\/FH.2013.37.3.555","volume":"37","author":"S Cruz-Pardos","year":"2013","unstructured":"Cruz-Pardos S, Garc\u00eda-Poza P, S\u00e1nchez-Garc\u00eda FJ (2013) Treatment with cyclodextrin for Niemann-Pick s disease (Article in Spanish). Farm Hosp 37(3):271\u2013272. doi:\n                        10.7399\/FH.2013.37.3.555","journal-title":"Farm Hosp"},{"issue":"1","key":"2833_CR31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s11096-014-0039-2","volume":"37","author":"AM Valle","year":"2015","unstructured":"Valle AM, Gonz\u00e1lez MC, Mor\u00f3n R, Ruiz S, Cabeza J (2015) Hydroxypropyl-beta cyclodextrin in Niemann-Pick type C disease. Int J Clin Pharm 37(1):282. doi:\n                        10.1007\/s11096-014-0039-2","journal-title":"Int J Clin Pharm"},{"key":"2833_CR32","unstructured":"Rodr\u00edguez R, De Santos MT, Natera D, Fern\u00e1ndez MI, Grasa CD, Taboas A et al (2015) Nuevas expectativas de tratamiento de Niemann pick tipo C [Article in Spanish] XXXVIII Anual Meeting SENEP: abstract PO 147. \n                        http:\/\/www.senep2015.com\/images\/site\/comunicaciones_aceptadas\/Posters_Orales.pdf\n                        \n                    . Accessed 06 May 2016"},{"issue":"366","key":"2833_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jns.2016.04.048","volume":"15","author":"AA Garc\u00eda-Robles","year":"2016","unstructured":"Garc\u00eda-Robles AA, Company-Albir MJ, Meg\u00edas-Vericat JE et al (2016) Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann-Pick type C patients. J Neurol Sci 15(366):65\u201367. doi:\n                        10.1016\/j.jns.2016.04.048","journal-title":"J Neurol Sci"},{"key":"2833_CR34","unstructured":"Vieira C (2011) The use of Cyclodextrin in Niemann-Pick Type C disease in two girls: Report after one year of treatment. Michael, Marcia, and Christa Parseghian Scientific Conference for Niemann- Pick Type C Research June 9\u201311, 2011. Abstract 28:28. \n                        https:\/\/niemannpick.nd.edu\/assets\/52702\/all_abstracts.pdf\n                        \n                    . Accessed 06 May 2016"},{"key":"2833_CR35","unstructured":"Vieira C, Lucena R (2012) Use of cyclodextrin in two Brazilian girls with Niemann-Pick type C: intrathecal report. Michael, Marcia, and Christa Parseghian Scientific Conference for Niemann- Pick Type C Research June 7\u20139, 2012. Abstract 10:18. \n                        https:\/\/niemannpick.nd.edu\/assets\/69394\/abstracts_in_speaking_order.pdf\n                        \n                    . Accessed 06 May 2016"},{"key":"2833_CR36","unstructured":"Vieira C, Jagersbacher JB, D\u00f3rea I, Costa F and Lucena R (2014) Use of cyclodextrin in two Brazilian girls with Niemann-Pick disease type C. ICNC, 2. Neurogenetics (P338-P372). JICNA, 1(Suppl I);124. doi:\n                        http:\/\/dx.doi.org\/10.17724\/jicna.2014.s1.pos12"},{"issue":"1","key":"2833_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ymgme.2012.11.005","volume":"108","author":"M Matsuo","year":"2013","unstructured":"Matsuo M, Togawa M, Hirabaru K, Mochinaga S, Narita A, Adachi M et al (2013) Effects of cyclodextrin in two patients with Niemann-Pick Type C disease. Mol Genet Metab 108(1):76\u201381. doi:\n                        10.1016\/j.ymgme.2012.11.005","journal-title":"Mol Genet Metab"},{"key":"2833_CR38","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ymgmr.2014.08.004","volume":"1","author":"M Matsuo","year":"2014","unstructured":"Matsuo M, Shraishic K, Wadad K, Ishitsukac Y, Doia H, Maedab M et al (2014) Effects of intracerebroventricular administration of 2-hydroxypropyl-\u03b2-cyclodextrin in a patient with Niemann-Pick Type C disease. Mol Genet Metab Rep 1:391\u2013400. doi:\n                        10.1016\/j.ymgmr.2014.08.004","journal-title":"Mol Genet Metab Rep"},{"issue":"S1","key":"2833_CR39","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/j.jns.2015.08.719","volume":"357","author":"Y Sakiyama","year":"2015","unstructured":"Sakiyama Y, Shibata S, Sanayama H, Ono S, Maekawa M, Matsuo M et al (2015) Intrathecal 2-hydroxypropyl-beta-cyclodextrin (HPBCD) therapy in adult-onset Niemann-Pick disease type C (NPC). J Neurol Sci 357(S1):e20. doi:\n                        10.1016\/j.jns.2015.08.719","journal-title":"J Neurol Sci"},{"issue":"1","key":"2833_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ajmg.b.30969","volume":"153B","author":"NM Yanjanin","year":"2010","unstructured":"Yanjanin NM, Velez JI, Gropman A, King K, Bianconi SE, Conley SK et al (2010) Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet 153B(1):132\u2013140. doi:\n                        10.1002\/ajmg.b.30969","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"2833_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2006.05.054","volume":"249","author":"C Iturriaga","year":"2006","unstructured":"Iturriaga C, Pineda M, Fern\u00e1ndez-Valero EM, Vanier MT, Coll MJ (2006) Niemann-Pick C disease in Spain: clinical spectrum and development of a disability scale. J Neurol Sci 249(1):1\u20136. doi:\n                        10.1016\/j.jns.2006.05.054","journal-title":"J Neurol Sci"},{"key":"2833_CR42","unstructured":"Porter FD, Yanjanin N, Liu A, Shankar R, Ory D, Pavan B et al (2014) Therapeutic trials for Niemann-Pick disease, type C1: 2-hydroxypropyl-\u03b2-cyclodextrin. Michael, Marcia, and Christa Parseghian Scientific Conference for Niemann-Pick Type C Research June 12-14, 2014. Abstract 7:18. \n                        https:\/\/niemannpick.nd.edu\/assets\/135126\/2014abstractbooklet.pdf\n                        \n                    . Accessed 06 May 2016"},{"key":"2833_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1194\/jlr.M700525-JLR200","volume":"49","author":"B Liu","year":"2008","unstructured":"Liu B, Li H, Repa JJ, Turley SD, Dietschy JM (2008) Genetic variations and treatments that affect the lifespan of the NPC1 mouse. J Lipid Res 49:663\u2013669. doi:\n                        10.1194\/jlr.M700525-JLR200","journal-title":"J Lipid Res"},{"key":"2833_CR44","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.ymgme.2010.11.148","volume":"102","author":"C Vite","year":"2011","unstructured":"Vite C, Mauldin E, Ward S, Stein V, Prociuk M, Haskins ME et al (2011) Intrathecal cyclodextrin therapy of feline Niemann-Pick Type C disease. Mol Genet Metab 102:S44. doi:\n                        10.1016\/j.ymgme.2010.11.148","journal-title":"Mol Genet Metab"},{"key":"2833_CR45","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1016\/j.ymgme.2015.12.411","volume":"117","author":"FD Porter","year":"2016","unstructured":"Porter FD, Farhat NY, Ottinger EA, McKew JC, Weissfeld L, Machielse B et al (2016) 1\/2 evaluation of intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin for the treatment of Niemann-Pick disease type C1. Mol Genet Metab 117:S97. doi:\n                        10.1016\/j.ymgme.2015.12.411","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2833_CR46","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1194\/jlr.D058487","volume":"56","author":"R Sidhu","year":"2015","unstructured":"Sidhu R, Jiang H, Farhat NY, Carrillo-Carrasco N, Woolery M, Ottinger E et al (2015) A validated LC-MS\/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid. J Lipid Res 56(6):1222\u20131233. doi:\n                        10.1194\/jlr.D058487","journal-title":"J Lipid Res"},{"key":"2833_CR47","unstructured":"Committee for Human Medicinal Products (CHMP), European Medicines Agency (EMA). Background review for cyclodextrins used as excipients. In the context of the revision of the guideline on \u2018Excipients in the label and package leaflet of medicinal products for human use\u2019. 2014. (CPMP\/463\/00 Rev. 1). \n                        http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2014\/12\/WC500177936.pdf\n                        \n                    . Accessed 06 May 2016"},{"issue":"5","key":"2833_CR48","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10162-015-0528-6","volume":"16","author":"S Cronin","year":"2015","unstructured":"Cronin S, Lin A, Thompson K, Hoenerhoff M, Duncan RK (2015) Hearing Loss and Otopathology Following Systemic and Intracerebroventricular Delivery of 2-Hydroxypropyl-Beta-Cyclodextrin. J Assoc Res Otolaryngol 16(5):599\u2013611. doi:\n                        10.1007\/s10162-015-0528-6","journal-title":"J Assoc Res Otolaryngol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-2833-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-2833-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-2833-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T07:05:37Z","timestamp":1495523137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-2833-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2833"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-2833-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}